Business Summary
Develops stem cell therapies for treating diabetes and cardiac injury. The Company is dedicated to the advancement of regenerative medicine. NSCI also plans to develop a genetically diverse umbilical cord blood bank to meet the growing need for transplant grade umbilical cord blood stem cells.
Country of Incorporation
United States of America
Incorporation Date
-
Business Sector
Pharmaceuticals & Medical Research
Company Address
17 State Street, 39th Floor